Drugs / Chuanhong Zhongfeng capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06874140 | Jan 2022 → Jan 2025 | ischemic stroke | Yingyue Ding | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chuanhong Zhongfeng capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06874140 ↗ |
| Known as | CHZF Capsule | “The study focused on identifying unique differential proteins in ACI patients treated with CHZF Capsule.” PMID 40517620 ↗ Jun 2025 |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese Medicine (TCM) compounds in ACI prevention and treatment” PMID 40517620 ↗ Jun 2025 |